These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7868152)

  • 101. Complement activation in discordant hepatic xenotransplantation.
    Tector AJ; Chen X; Soderland C; Tchervenkov JI
    Xenotransplantation; 1998 Nov; 5(4):257-61. PubMed ID: 9915253
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Endothelial cell activation and thromboregulation during xenograft rejection.
    Bach FH; Robson SC; Ferran C; Winkler H; Millan MT; Stuhlmeier KM; Vanhove B; Blakely ML; van der Werf WJ; Hofer E; de Martin R; Hancock WW
    Immunol Rev; 1994 Oct; 141():5-30. PubMed ID: 7868157
    [No Abstract]   [Full Text] [Related]  

  • 103. The vascular and coagulation issues in xenotransplantation.
    Cowan PJ; Roussel JC; d'Apice AJ
    Curr Opin Organ Transplant; 2009 Apr; 14(2):161-7. PubMed ID: 19469030
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction.
    Cantu E; Gaca JG; Palestrant D; Baig K; Lukes DJ; Gibson SE; Gonzalez-Stawinski GV; Olausson M; Parker W; Davis RD
    Transplantation; 2006 Apr; 81(8):1157-64. PubMed ID: 16641602
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Innate cellular immunity and xenotransplantation.
    Wang H; Yang YG
    Curr Opin Organ Transplant; 2012 Apr; 17(2):162-7. PubMed ID: 22262106
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Genetic engineering for xenotransplantation.
    Sandrin MS; Loveland BE; McKenzie IF
    J Card Surg; 2001; 16(6):448-57. PubMed ID: 11925025
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Recent advances in the immunology of xenotransplantation.
    Takahashi T; Saadi S; Platt JL
    Immunol Res; 1997; 16(3):273-97. PubMed ID: 9379077
    [TBL] [Abstract][Full Text] [Related]  

  • 108. T cell-mediated xenograft rejection: specific tolerance is probably required for long term xenograft survival.
    Dorling A; Lechler RI
    Xenotransplantation; 1998 Nov; 5(4):234-45. PubMed ID: 9915251
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejection.
    Zeyland J; Gawrońska B; Juzwa W; Jura J; Nowak A; Słomski R; Smorąg Z; Szalata M; Woźniak A; Lipiński D
    J Appl Genet; 2013 Aug; 54(3):293-303. PubMed ID: 23780397
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The natural immune barrier to xenotransplantation.
    Geller RL; Turman MA; Dalmasso AP; Platt JL
    J Am Soc Nephrol; 1992 Dec; 3(6):1189-200. PubMed ID: 1477315
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Experimental discordant hepatic xenotransplantation in the recipient with liver failure: implications for clinical bridging trials.
    Tector AJ; Fridell JA; Ruiz P; Khurana RJ; Jensen G; Mak A; Greinke D; Salazar J; Stevenson W; Metrakos P; Tchervenkov J
    J Am Coll Surg; 2000 Jul; 191(1):54-64. PubMed ID: 10898184
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation.
    Ma Y; Xie B; Guo J; Chen Y; Zhong M; Lin Q; Hua J; Zhong J; Luo X; Yan G; Dai H; Qi Z
    Cell Transplant; 2021; 30():9636897211054503. PubMed ID: 34814739
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pathological features of antibody-mediated rejection.
    Shimizu A; Colvin RB
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):199-214. PubMed ID: 15975034
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Pulmonary xenotransplantation: rapidly progressing into the unknown.
    Cantu E; Parker W; Platt JL; Duane Davis R
    Am J Transplant; 2004; 4 Suppl 6():25-35. PubMed ID: 14871271
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Therapeutic strategies for xenograft rejection.
    Lin SS
    J Card Surg; 2001; 16(5):374-82. PubMed ID: 11885768
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium.
    Chen D; Weber M; McVey JH; Kemball-Cook G; Tuddenham EG; Lechler RI; Dorling A
    Am J Transplant; 2004 Dec; 4(12):1958-63. PubMed ID: 15575897
    [TBL] [Abstract][Full Text] [Related]  

  • 117. CD47: a new player in phagocytosis and xenograft rejection.
    Navarro-Alvarez N; Yang YG
    Cell Mol Immunol; 2011 Jul; 8(4):285-8. PubMed ID: 21258362
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Transplantation of discordant xenografts: a review of progress.
    Platt JL; Vercellotti GM; Dalmasso AP; Matas AJ; Bolman RM; Najarian JS; Bach FH
    Immunol Today; 1990 Dec; 11(12):450-6; discussion 456-7. PubMed ID: 2073317
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Mechanisms of rejection: current perspectives.
    Wood KJ; Goto R
    Transplantation; 2012 Jan; 93(1):1-10. PubMed ID: 22138818
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Blockade of Extracellular HMGB1 Suppresses Xenoreactive B Cell Responses and Delays Acute Vascular Xenogeneic Rejection.
    Li JH; Zhao B; Zhu XH; Wang L; Zou HJ; Chen S; Guo H; Ruan YL; Zheng F; Xiang Y; Ming CS; Gong FL; Chen G
    Am J Transplant; 2015 Aug; 15(8):2062-74. PubMed ID: 25943147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.